Aquestive Therapeutics, Inc.
AQSTHealthcare|Drug Manufacturers - Specialty & Generic|US
$3.61
-0.05 (-1.37%)
Cash / Share
$0.72
Clinical Trials (11)
| Trial | Conditions | Phase | Status | Enrollment | Design | Drug |
|---|---|---|---|---|---|---|
| NCT03428360 Safety and Tolerability Study of Diazepam Buccal Film (DBF) in Subjects With Epilepsy | Epilepsy | P3 | Completed | 149 | Open-label | Diazepam Buccal Soluble Film 5, 7.5,10, 12.5,15 or 17.5 mg with individual dose determined according to age and weight category |
| NCT03457753 Riluzole Oral Soluble Film Safety and Tolerability in Amyotrophic Lateral Sclerosis | ALS | P2 | Withdrawn | — | Open-label | Riluzole Oral Soluble Film |
| NCT03179891 Study of Diazepam Buccal Film Administered in the Interictal and in the Ictal-Periictal States to Adults With Epilepsy | Epilepsy | P2 | Completed | 35 | Open-label | Diazepam Buccal Film 12.5 mg |
| NCT03679975 Riluzole Oral Soluble Film (ROSF) Swallowing Safety in Amyotrophic Lateral Sclerosis (ALS) | Amyotrophic Lateral Sclerosis | P2 | Terminated | 9 | Open-label | Riluzole Oral Soluble film (ROSF) 50 mg |
| NCT03953820 Diazepam Buccal Film (DBF) - Diastat Rectal Gel (DRG) Crossover Study | Epilepsy | P1P2 | Completed | 31 | RCT, Open-label | Diazepam Buccal Film, Diastat® Rectal Gel (Valeant Pharmaceuticals USA) |
| NCT03222349 Pharmacokinetics and Safety Study of Diazepam Buccal Film (DBF) in Pediatric Subjects With Epilepsy | Epilepsy | P2 | Completed | 24 | Open-label | Diazepam Buccal Film |
| NCT01217190 Crossover Study Comparing Ondansetron Orally Dissolving Film Strip (ODFS) With Zofran Orally Disintegrating Tablets | Nausea and Vomiting, Postoperative, Nausea With Vomiting Chemotherapy-Induced | P1P2 | Completed | 48 | RCT, Open-label | Ondansetron (ODFS), Zofran (ODT) |
| NCT06527937 Pharmacokinetics Study of DESF in Adults With Oral Allergy Syndrome | Allergic Reaction | P2 | Completed | 36 | RCT, Open-label | DESF, Epinephrine Injection |
| NCT01220167 Three-way Crossover Study Comparing Ondansetron ODFS Administered With and Without Water to Zofran ODT Without Water | Healthy Participants | P1 | Completed | 18 | RCT, Open-label | Ondansetron 8 mg ODFS without water, Ondansetron 8 mg ODFS with water, Zofran ODT (ondansetron 8 mg) without water |
| NCT07703982 A Study to Evaluate the Pharmacokinetics, Pharmacodynamics, and Safety of DESF in Pediatric Subjects | Allergic Reaction | P1 | Completed | 32 | Open-label | DESF |
| NCT01217801 Two Way Bioequivalence Study Under Fed Conditions | Healthy | P1 | Completed | 48 | RCT, Open-label | Ondansetron (ODFS), Ondansetron (ODT) |